Feasibility of Neonatal Screening for Spinal Amyotrophy
1 clinical trials · Condition
◉ Watch Feasibility of Neonatal Screening for Spinal Amyotrophy
| Record | Firm | Date |
|---|---|---|
| Feasibility of a Newborn Screening for Spinal Muscular Atrophy (SMA) in France: DEPISMA Prefigurator Project in Grand-Est and Nouvelle-Aquitaine (NCT05645250) | University Hospital, Strasbourg, France | 2022-12-13 |
Track Feasibility of Neonatal Screening for Spinal Amyotrophy automatically
Every clearance here is in the API, with alerts when new ones post.